Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ENGN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
23 top institutions tracked
Sentiment: neutral
Last trade: buy 20 days ago
Red flags: 1
60 filers reported a long position in ENGN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FCPM III SERVICES B.V. | $16.7M | 9.6M | Unchanged |
| BML Capital Management, LLC | $11.5M | 6.7M | New |
| Siren, L.L.C. | $10.8M | 6.3M | +19.1% |
| PERCEPTIVE ADVISORS LLC | $8.3M | 4.8M | -17.3% |
| AMERIPRISE FINANCIAL INC | $4.6M | 2.7M | New |
| Nextech Invest Ltd. | $4M | 2.3M | Unchanged |
| ADAR1 Capital Management, LLC | $3.6M | 2.1M | +1,474.6% |
| Vestal Point Capital, LP | $2.9M | 1.7M | -23% |
| ACORN CAPITAL ADVISORS, LLC | $2.2M | 1.3M | New |
| Peapod Lane Capital LLC | $1.9M | 1.1M | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.